Disclosed are chemical entities of formula (I) wherein X, Y, Z, R1, R3, R4, R5 and R6 are defined herein, as NR2B subtype selective receptor antagonists. Also disclosed are pharmaceutical compositions comprising a chemical entity of formula (I), and methods of treating various diseases and disorders associated with NR2B antagonism, e.g., diseases and disorders of the CNS, such as depression, by administering a chemical entity of formula I.
本文披露了
化学实体的结构式(I),其中X、Y、Z、R1、R3、R4、R5和R6的定义如本文所述,作为NR2B亚型选择性受体拮抗剂。还披露了包括结构式(I)的
化学实体的药物组合物,以及通过给予结构式I的
化学实体治疗与NR2B拮抗作用相关的各种疾病和障碍的方法,例如中枢神经系统的疾病和障碍,如抑郁症。